Cost Effectiveness-3
g~FACT~h
In the U.S the use of PET in lung and colorectal cancer would reduce costs by $200 million and $75 million respectively; due to avoided unnecessary surgical procedures and unnecessary biopsies
Previous slide
Next slide
Back to first slide
View graphic version